Neuroquiescence—a treatment for neurological and nervous system bioelectrical dysregulation associated with seizures of epilepsy
US10716792B2 · kind B2 · utility
1Cited by
9References
20Claims
0Family size
Inventors
Key dates
| Filing date | Nov 27, 2019 |
| Grant date | Jul 21, 2020 |
| Priority date | — |
| Expiry date | Nov 27, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present inventive concept describes a method for treating the neurovascular disruption underlying Epileptic Seizures and other traits of Epilepsy and Infantile Spasms by improving the neurophysiological environment and then enabling by sustained sedation a biomechanism of glial cells for neuronal repairs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.